November 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreOctober 01, 2025
The medical device CMO and CDMO market size is is set to grow significantly, driven by evolving consumer prefe...
Read MoreNovember 01, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 01, 2025
According to market projections, the South Korea breast pump sector is expected to grow from USD 20.41 million in 2024 to USD 41.66 million by 2034, reflecting a CAGR of 7.44%. In 2024, closed-system breast pumps led the South Korea market and will grow fastest, while open-system pumps will gain a notable share. Electric pumps dominated and will se...
November 01, 2025
According to market projections, the iron deficiency anemia therapy sector is expected to grow from USD 5.24 billion in 2024 to USD 10.94 billion by 2034, reflecting a CAGR of 7.64%. In 2024, North America led the global iron deficiency anemia therapy market with a 37% share. The Asia-Pacific region is expected to grow the fastest. Parenteral iron ...
November 01, 2025
Market insights predict the global biologics CDMO industry will increase from USD 22 billion in 2024 to USD 92.79 billion by 2034, achieving a CAGR of 15.48%. In 2024, North America led the biologics CDMO market with 37% share. Asia-Pacific is expected to grow fastest. Mammalian types dominated, while microbial types are set to expand. Monoclonal a...
November 01, 2025
Projections indicate the global chemotherapy market will increase from USD 9.57 billion in 2024 to USD 19.35 billion by 2034, experiencing a CAGR of 7.56% over the next 10 years. In 2024, North America led the global chemotherapy market with a 45% share. The Asia Pacific region is expected to grow the fastest. Alkylating agents dominated, while leu...
November 01, 2025
Forecasts suggest that the digital biomarkers market will expand from USD 4.15 billion in 2024 to USD 32.37 billion by 2034, with a CAGR of 22.74% during this period. The rise has been attributed to the growing need for remote patient monitoring services, the fast improvement of healthcare technology, the increased popularity of current advances, a...
November 01, 2025
According to market projections, the recombinant proteins sector is expected to grow from USD 3.05 billion in 2024 to USD 8.08 billion by 2034, reflecting a CAGR of 10.24%. In 2024, North America led the global recombinant proteins market with a 42% share. The cytokines & growth factors segment dominated by product, while antibodies are set for...
November 01, 2025
According to market projections, the global U.S. concierge medicine market, valued at USD 7.25 billion in 2024, is anticipated to reach USD 19.36 billion by 2034, growing at a CAGR of 10.36% over the next decade. In 2024, the group segment dominated the U.S. concierge medicine market by ownership, while the standalone segment is set to grow at the ...
November 01, 2025
Forecasts suggest that the nootropics market will expand from USD 4.98 billion in 2024 to USD 19.53 billion by 2034, with a CAGR of 14.64% during this period. In 2024, North America led the nootropics market, while Asia Pacific is set for the fastest growth. Capsules/tablets dominated by form, but drinks will grow the quickest. Offline channels led...
November 01, 2025
According to market projections, the APAC viral vector and plasmid DNA manufacturing sector is expected to grow from USD 1.38 billion in 2024 to USD 10.01 billion by 2034, reflecting a CAGR of 21.93%. In 2024, the APAC viral vector and plasmid DNA manufacturing market saw adeno-associated viruses dominate by vector type, while cancer led by disease...
November 01, 2025
Market insights predict the global blood based biomarkers industry will increase from USD 7.89 billion in 2024 to USD 15.78 billion by 2034, achieving a CAGR of 7.24%. In 2024, North America led the global blood-based biomarkers market, while Asia-Pacific is set for the fastest growth. Genetic biomarkers dominated by type, but cell-based biomarkers...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com